Cargando…
Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211055/ https://www.ncbi.nlm.nih.gov/pubmed/32388748 http://dx.doi.org/10.1007/s10067-020-05145-w |
| _version_ | 1783531385896566784 |
|---|---|
| author | Ahmed, Sakir Anirvan, Prajna |
| author_facet | Ahmed, Sakir Anirvan, Prajna |
| author_sort | Ahmed, Sakir |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7211055 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer London |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72110552020-05-11 Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? Ahmed, Sakir Anirvan, Prajna Clin Rheumatol Letter to the Editor Springer London 2020-05-09 2020 /pmc/articles/PMC7211055/ /pubmed/32388748 http://dx.doi.org/10.1007/s10067-020-05145-w Text en © International League of Associations for Rheumatology (ILAR) 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Ahmed, Sakir Anirvan, Prajna Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? |
| title | Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? |
| title_full | Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? |
| title_fullStr | Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? |
| title_full_unstemmed | Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? |
| title_short | Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19? |
| title_sort | reply to rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for covid-19? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211055/ https://www.ncbi.nlm.nih.gov/pubmed/32388748 http://dx.doi.org/10.1007/s10067-020-05145-w |
| work_keys_str_mv | AT ahmedsakir replytorheumatologistsperspectiveoncoronavirusdisease19isheparinthedarkhorseforcovid19 AT anirvanprajna replytorheumatologistsperspectiveoncoronavirusdisease19isheparinthedarkhorseforcovid19 |